In 2013, the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the National
Cancer Institute (NCI) partnered for the first time to host a joint workshop on targeted …

The growing interest in targeted radionuclide therapy (TRT) for a broad range of applications
is shared by a diverse group of medical professionals, including but not limited to physicians …

This collection of reviews and papers on targeted radionuclide therapy provides a snapshot
of the current status of modern clinical applications of therapeutic nuclear medicine. The …

Abstract The 30th Annual Congress of the European Association of Nuclear Medicine
(EANM) was held in Vienna, Austria, from 21 to 25 October 2017 under the chairmanship of …

In recent years, targeted radionuclide therapy (TRT) has emerged as a promising strategy
for cancer treatment. In contrast to conventional radiotherapy, TRT delivers ionizing radiation …

Within nuclear medicine, theranostics has revitalized the field of targeted radionuclide
therapy, and there are a growing number of investigator-initiated and industry-sponsored …

The concept of targeted radionuclide therapy (TRT) relies on the use of injected nuclear
medicine as treating agents, targeted at the cellular or molecular level. The growth of the …

Medicine includes a report of a promising agent for the radiopharmaceutical therapy of
metastatic melanoma (1). The report is provocative for several reasons: it provides a …

OBJECTIVE. This article reviews recent developments in targeted radionuclide therapy
(TRT) approaches directed to malignant liver lesions, bone metastases, neuroendocrine …

Targeted radionuclide therapy (TRT) is a branch of cancer medicine concerned with the use
of radioisotopes, radiolabelled molecules, nanoparticles, or microparticles that either …